A chemocentric approach to the identification of cancer targets

Area of Science:

• Oncology
• Medicinal Chemistry
• Computational Biology

Background:

• Identifying novel cancer drug targets is crucial for developing effective therapeutics.
• Existing methods may not fully exploit the potential of chemical libraries for target discovery.

Purpose of the Study:

• To introduce and validate a novel chemocentric strategy for identifying cancer-relevant protein targets.
• To leverage differential cytotoxicity screening and virtual target profiling for enhanced drug discovery.

Main Methods:

• Utilized a large chemical collection for screening against HCT116 (tumor) and MRC-5 (normal) cell lines.
• Applied differential virtual target profiling to selective small molecule hits.
• Combined in vitro and in silico screenings (DIVISS) for target identification.

Main Results:

• Identified 115 proteins uniquely hit by compounds with selective antiproliferative effects on tumor cells.
• Validated known cancer drug targets and discovered additional potential targets.
• Demonstrated the efficacy of the DIVISS approach in cancer target discovery.

Conclusions:

• The DIVISS approach is effective for identifying both established and novel cancer targets.
• The identified protein list offers potential for developing synergistic cancer therapeutics.
• This chemocentric strategy advances the field of targeted cancer drug discovery.